A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial

S Hyttel-Sorensen; T. Austin; F. van Bel; M.J.N.L. Benders; O. Claris; E. Dempsey; M. Fumagalli; G Greisen; B Grevstad; C. Hagmann; L Hellstrom-Westas; P.M.A. Lemmers; J Lindschou; G. Naulaers; W. van Oeveren; A. Pellicer; G Pichler; C Roll; M Skoog; P Winkel; M. Wolf; C. Gluud

doi:10.1186/1745-6215-14-120

A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial

Translated title of the contribution: A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial

S Hyttel-Sorensen
, T. Austin
, F. van Bel
, M.J.N.L. Benders
, O. Claris
, E. Dempsey
, M. Fumagalli
, G Greisen
, B Grevstad
, C. Hagmann
, L Hellstrom-Westas
, P.M.A. Lemmers
, J Lindschou
, G. Naulaers
, W. van Oeveren
, A. Pellicer
, G Pichler
, C Roll
, M Skoog
, P Winkel

M. Wolf, C. Gluud

Birth Center Neonatology - Medical

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial
Original language	Undefined/Unknown
Article number	120
Pages (from-to)	120
Number of pages	1
Journal	Trials [E]
Volume	14
DOIs	https://doi.org/10.1186/1745-6215-14-120
Publication status	Published - 2013

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

10.1186/1745-6215-14-120

http://www.ncbi.nlm.nih.gov/pubmed/23782447

Cite this

Hyttel-Sorensen, S., Austin, T., van Bel, F., Benders, M. J. N. L., Claris, O., Dempsey, E., Fumagalli, M., Greisen, G., Grevstad, B., Hagmann, C., Hellstrom-Westas, L., Lemmers, P. M. A., Lindschou, J., Naulaers, G., van Oeveren, W., Pellicer, A., Pichler, G., Roll, C., Skoog, M., ... Gluud, C. (2013). A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial. Trials [E], 14, 120. Article 120. https://doi.org/10.1186/1745-6215-14-120

@article{80e8cc0f86aa4e0f9daba1dcaf162288,

title = "A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "S Hyttel-Sorensen and T. Austin and \{van Bel\}, F. and M.J.N.L. Benders and O. Claris and E. Dempsey and M. Fumagalli and G Greisen and B Grevstad and C. Hagmann and L Hellstrom-Westas and P.M.A. Lemmers and J Lindschou and G. Naulaers and \{van Oeveren\}, W. and A. Pellicer and G Pichler and C Roll and M Skoog and P Winkel and M. Wolf and C. Gluud",

year = "2013",

doi = "10.1186/1745-6215-14-120",

language = "Undefined/Unknown",

volume = "14",

pages = "120",

journal = "Trials [E]",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

}

Hyttel-Sorensen, S, Austin, T, van Bel, F, Benders, MJNL, Claris, O, Dempsey, E, Fumagalli, M, Greisen, G, Grevstad, B, Hagmann, C, Hellstrom-Westas, L, Lemmers, PMA, Lindschou, J, Naulaers, G, van Oeveren, W, Pellicer, A, Pichler, G, Roll, C, Skoog, M, Winkel, P, Wolf, M & Gluud, C 2013, 'A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial', Trials [E], vol. 14, 120, pp. 120. https://doi.org/10.1186/1745-6215-14-120

A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial. / Hyttel-Sorensen, S; Austin, T.; van Bel, F. et al.
In: Trials [E], Vol. 14, 120, 2013, p. 120.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial

AU - Hyttel-Sorensen, S

AU - Austin, T.

AU - van Bel, F.

AU - Benders, M.J.N.L.

AU - Claris, O.

AU - Dempsey, E.

AU - Fumagalli, M.

AU - Greisen, G

AU - Grevstad, B

AU - Hagmann, C.

AU - Hellstrom-Westas, L

AU - Lemmers, P.M.A.

AU - Lindschou, J

AU - Naulaers, G.

AU - van Oeveren, W.

AU - Pellicer, A.

AU - Pichler, G

AU - Roll, C

AU - Skoog, M

AU - Winkel, P

AU - Wolf, M.

AU - Gluud, C.

PY - 2013

Y1 - 2013

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

U2 - 10.1186/1745-6215-14-120

DO - 10.1186/1745-6215-14-120

M3 - Article

C2 - 23782447

SN - 1745-6215

VL - 14

SP - 120

JO - Trials [E]

JF - Trials [E]

M1 - 120

ER -

Hyttel-Sorensen S, Austin T, van Bel F, Benders MJNL, Claris O, Dempsey E et al. A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial. Trials [E]. 2013;14:120. 120. doi: 10.1186/1745-6215-14-120